Tumor angiogenesis: A physiological process or genetically determined?
- 1 June 1996
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 15 (2) , 205-212
- https://doi.org/10.1007/bf00437473
Abstract
Continued tumor growth is dependent upon the growth of new blood vessels. This commentary reviews the mechanisms whereby tumors become vascularized and examines whether tumor angiogenesis is solely an example of a normal physiologic process or is part of the genetic program of the tumor. The likelihood that neovascularization of tumors combines both of these components, that is, utilizing tumor-specific elements as well as capacities common to all cells, is discussed.Keywords
This publication has 36 references indexed in Scilit:
- Life (and death) in a malignant tumourNature, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 CellsPublished by Elsevier ,1995
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanomaCurrent Opinion in Oncology, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcomaCell, 1991
- Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor geneCell, 1989